Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending June 27, 2013. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares, executed under authority granted by shareholders at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, or debt levels. The only financial data disclosed relates to the share buyback transaction:
- Shares Purchased: 1,025,000 Ordinary Shares of 25 pence each.
- Transaction Date: June 27, 2013.
- Price Range: Highest price paid was 1,657.50 pence per share; lowest price paid was 1,625 pence per share.
- Treasury Holdings: Post-transaction, the company holds 515,639,512 shares in Treasury (9.50% of total issued share capital).
- Voting Rights Impact: Including unsettled purchases, Treasury holdings represent 10.56% of current total voting rights.
- Shares in Issue: 4,914,574,759 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of outstanding shares through the repurchase of 1,025,000 shares. Consequently, the percentage of shares held in Treasury increased to 9.50% of total issued share capital. The filing does not provide comparative data against prior periods for operational metrics.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Conduct Authority's Disclosure and Transparency Rules. The company intends to hold the repurchased shares in Treasury.
Investor Verification Checklist
- Verify the total cost of the 1,025,000 share repurchase based on the disclosed price range (1,625 to 1,657.50 pence).
- Confirm the updated total issued share capital and the specific impact on earnings per share (EPS) calculations.
- Review the remaining authorization limit for share buybacks under the May 1, 2013 shareholder mandate.
- Check subsequent filings for the settlement status of the shares mentioned as "purchased but not yet settled."